Description
* Cagrilintide
Long-acting amylin receptor agonist peptide
Studied in research for its effects on:
• Appetite suppression & satiety signaling
• Delayed gastric emptying
• Reduction in food intake
• Synergistic effects with GLP-1 agonists
• Metabolic regulation & body weight control
Potent amylin analogue with prolonged half-life, widely used in preclinical studies (often in combination with GLP-1 agonists like semaglutide) to investigate dual-hormone approaches to obesity and metabolic disease.
For research use only. Not for human consumption.






Reviews
There are no reviews yet.